Stay updated on Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.

Latest updates to the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page
- CheckyesterdayChange DetectedExpanded study footprint with 6 new locations across Europe and South America, bringing total sites to 472; updated status and last update timestamp. The page now reflects broader geographic coverage and updated location data.SummaryDifference1.0%
- Check8 days agoChange DetectedNew locations and contacts added (global sites), with location count increasing from 461 to 466; several outdated or previously listed contacts/labels removed. Overall, the page’s core content (locations, contacts, status) has expanded and been refreshed.SummaryDifference1%
- Check16 days agoChange Detected- Core update: page revision to v3.2.0 with new study locations and expanded location counts. - Added numerous new locations across multiple countries and updated contact details. - Removed older counts and old contact line, and dropped 457-location reference in favor of 461 locations, plus updated dates (2025-09-24 present in additions) and newer revision.SummaryDifference0.8%
- Check17 days agoChange DetectedSignificant additions: new study sites and locations worldwide, expanded contact details, and an updated total location count (461). Removed: older date stamp and reference to 457 locations and older contact format.SummaryDifference0.8%
- Check24 days agoChange DetectedAdded a new study site in Poland and increased total locations to 457; removed earlier mentions of counterfeit/substandard drug-related categories and the previous total of 456.SummaryDifference0.2%
- Check31 days agoChange DetectedAdded two new sites (Tan Tock Seng Hospital - Site 4800 in Singapore; Hospital Sultanah Aminah - Site 4702 in Johor) and updated the Shenzhen site naming and contacts, bringing total locations to 456 and updating to Revision v3.0.2 dated 2025-09-10; removed the older 454-location count and outdated contact/department qualifier.SummaryDifference0.5%
Stay in the know with updates to Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tulisokibart Efficacy Safety Ulcerative Colitis Clinical Trial page.